James Paul Kastenmayer

General Counsel, Viela Bio, Inc.

Companies

ArriVent BioPharma, Inc.General counsel Jan 25, 2024 to now¹
Aeglea BioTherapeuticsGeneral counsel Aug 25, 2022 to Feb 24, 2023²
Aeglea BioTherapeuticsChief executive officer Aug 25, 2022 to Aug 25, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aeglea BioTherapeutics SYRE4,000 shares³$342.3K at $85.57Aug 25, 2022
ArriVent BioPharma, Inc. AVBP7,386 shares⁴$130.7K at $17.70Jan 25, 2024

As of each latest filing. The line shows shares held over time.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARArriVent BioPharma, Inc., General counsel
2
SEC EDGARAeglea BioTherapeutics, General counsel
3
SEC EDGARAeglea BioTherapeutics shares after the filing of Aug 25, 2022
4
SEC EDGARArriVent BioPharma, Inc. shares after the filing of Jan 25, 2024